News | Haoyisheng Guzheng Traditional Chinese Medicine Enters Strategic Cooperation with West China Medical Robot Research Institute to Build a New AI-powered Smart TCM Health Management Platform

On the morning of September 30, 2025, the strategic cooperation signing ceremony between Haoyisheng Guzheng Traditional Chinese Medicine and Jingchuang Gaoweidu of West China Medical Robot Research Institute was grandly held in Chengdu. Adhering to the principles of resource sharing, complementary advantages, comprehensive cooperation and win-win future, both parties will establish a long-term, stable and close strategic partnership to jointly advance the digital and intelligent upgrading of TCM health management services.
This cooperation will also deliver powerful technological empowerment and core support for the new TCM clinics under layout by FNY. Relevant leaders from Jingchuang Gaoweidu affiliated to West China Medical Robot Research Institute, FNY Biotechnology and Haoyisheng Guzheng Traditional Chinese Medicine attended the signing ceremony, which was hosted by Zhao Peilin, Director of Public Affairs of FNY.

Geng Yuechang, Chairman of FNY, Chairman and General Manager of Haoyisheng Guzheng Traditional Chinese Medicine, stated in his speech that as a professional smart TCM health management company nurtured by Good Doctor Group and an empowerment platform for FNY’s big health industry, Haoyisheng Guzheng Traditional Chinese Medicine commits itself to developing the “Medical Care, Wellness, Management & Research · Smart TCM” service system centered on TCM wellness, health management and chronic disease management. It aims to build a new four-in-one full-cycle smart TCM health management platform integrating medical treatment, health rehabilitation, health management and TCM research. He further pointed out that the online platform of Guzheng TCM and offline new TCM clinics of FNY together form the core framework of FNY’s smart health service system.
The strategic cooperation with Jingchuang Gaoweidu of West China Medical Robot Research Institute, leveraging the technological strengths of West China Hospital, Sichuan University, marks a pivotal step for the health management platform to deepen technological empowerment and accelerate the implementation of smart services. He believes that relying on Jingchuang Gaoweidu’s cutting-edge technologies and innovative products in the field of TCM artificial intelligence, the digital service capacity of Haoyisheng Guzheng Traditional Chinese Medicine will be greatly enhanced. It will empower FNY’s offline market system more efficiently, break the limitations of traditional TCM operation models, and promote the standardized, precise and personalized development of public health management services.



Witnessed by all guests, Liang Chaofu, Executive Deputy General Manager of Haoyisheng Guzheng Traditional Chinese Medicine, and Zeng Tian, Deputy General Manager of Jingchuang Gaoweidu of West China Medical Robot Research Institute, signed the agreement on behalf of both parties, signifying the official launch of this strategic cooperation. In accordance with the agreement, the two sides will carry out all-round and in-depth cooperation in multiple fields such as medical equipment promotion, joint product R&D, technical exchange support and health management software development, and jointly explore new models and boundaries of smart TCM health management services.

After the signing ceremony, Zeng Di, General Manager of Jingchuang Gaoweidu of West China Medical Robot Research Institute, presented an authorization certificate to Geng Yuechang, Chairman and General Manager of Haoyisheng Guzheng Traditional Chinese Medicine and Chairman of FNY. This means Haoyisheng Guzheng Traditional Chinese Medicine has officially become an important market partner of Jingchuang Gaoweidu for advanced intelligent TCM diagnosis and treatment equipment and solutions, and the cooperation has entered the substantive implementation phase.
This cooperation not only witnesses the alliance of two outstanding enterprises rooted in the big health sector, but also represents the in-depth integration of the essence of traditional Chinese medicine and modern artificial intelligence technology. As an important promoter of this cooperation, Good Doctor Group FNY Biotechnology will also be the first to benefit from the outcomes of the partnership.
In the future, both parties will give full play to their respective strengths in market insight, health management platforms, artificial intelligence R&D and professional medical expertise. They will jointly develop a new generation of intelligent health management platforms and integrated software and hardware solutions. Meanwhile, supported by FNY’s offline network and market channels, they will provide the public with more precise, convenient and intelligent full-life-cycle health services.

